'Triple-G' weight loss drug update: Even on the lowest dose, trial patients lost 12.7% of their weight
- Posted on October 1, 2026
- By Bing News
- 1 Views
- 1 min read
In brief
Generating AI summary…
'Triple-G' weight loss drug update: Even on the lowest dose, trial patients lost 12.7% of their weight
We’re learning more about the super-effective “triple-G” weight loss drug retatrutide. The drug, the first of its kind to target three metabolic receptors (GLP-1, GIP, and glucagon), is nearing the end of clinical trials and is expected to be submitted to the FDA for approval early next year. People are already clamoring to get their hands on it. Copycats of the unapproved drug have exploded on the gray peptide market with fans from menopausal...
